- Conspicuity of FDG-Avid Osseous Lesions on PET/MRI Versus PET/CT: a Quantitative and Visual Analysis
-
Fraum TJ, Fowler KJ, McConathy
- KMID: 2351647
- Nucl Med Mol Imaging.
- 2016 Sep;50(3):228-239.
- doi: 10.1007/s13139-016-0403-3
BACKGROUND: Because standardMRI-based attenuation correction (AC) does not account for the attenuation of photons by cortical bone, PET/MRI may have reduced sensitivity for FDG-avid focal bone lesions (FFBLs). This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Indeterminate Findings on Oncologic PET/CT: What Difference Does PET/MRI Make?
-
Fraum TJ, Fowler KJ, McConathy , Dehdashti
- KMID: 2386152
- Nucl Med Mol Imaging.
- 2016 Dec;50(4):292-299.
- doi: 10.1007/s13139-016-0405-1
BACKGROUND: Positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-[¹â¸F]fluoro-D-glucose (FDG) has become the standard of care for the initial staging and subsequent treatment response assessment of many different malignancies. Despite this... -
- CITED
-
- Close
- SHARE
-
- Close
